Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

1-year prospective real life monitoring of asthma control and quality of life in Italy.

Terzano C, Cremonesi G, Girbino G, Ingrassia E, Marsico S, Nicolini G, Allegra L; PRISMA (PRospectIve Study on asthMA control) Study Group.

Respir Res. 2012 Dec 6;13:112. doi: 10.1186/1465-9921-13-112.

2.

How air pollution influences clinical management of respiratory diseases. A case-crossover study in Milan.

Santus P, Russo A, Madonini E, Allegra L, Blasi F, Centanni S, Miadonna A, Schiraldi G, Amaducci S.

Respir Res. 2012 Oct 18;13:95. doi: 10.1186/1465-9921-13-95.

3.

Nasal filters in prevention of seasonal rhinitis induced by allergenic pollen grains. Open clinical study.

D'Amato G, Liccardi G, Salzillo A, Russo M, Narciso P, Allegra L.

Eur Ann Allergy Clin Immunol. 2012 Apr;44(2):83-5.

PMID:
22768728
4.

Hyaluronic acid : perspectives in lung diseases.

Allegra L, Della Patrona S, Petrigni G.

Handb Exp Pharmacol. 2012;(207):385-401. doi: 10.1007/978-3-642-23056-1_17. Review.

PMID:
22566234
5.

Seroprevalence of IgG anti-Toxocara species antibodies in a population of patients with suspected allergy.

Qualizza R, Incorvaia C, Grande R, Makri E, Allegra L.

Int J Gen Med. 2011;4:783-7. doi: 10.2147/IJGM.S24324. Epub 2011 Nov 22.

6.

The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism.

van Mastbergen J, Jolas T, Allegra L, Page CP.

Pulm Pharmacol Ther. 2012 Feb;25(1):55-61. doi: 10.1016/j.pupt.2011.10.007. Epub 2011 Nov 25.

PMID:
22138191
7.

Real-life prospective study on asthma control in Italy: cross-sectional phase results.

Allegra L, Cremonesi G, Girbino G, Ingrassia E, Marsico S, Nicolini G, Terzano C; PRISMA (PRospectIve Study on asthMA control) Study Group.

Respir Med. 2012 Feb;106(2):205-14. doi: 10.1016/j.rmed.2011.10.001. Epub 2011 Oct 28.

8.

Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation--the Italian SOS (Stratification Observational Study).

Lusuardi M, Blasi F, Terzano C, Cricelli C, Crispino N, Comarella L, De Benedetto F, Sanguinetti CM, Allegra L, Donner CF.

Monaldi Arch Chest Dis. 2009 Dec;71(4):153-60.

PMID:
20440919
9.

Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study.

Terzano C, Conti V, Di Stefano F, Petroianni A, Ceccarelli D, Graziani E, Mariotta S, Ricci A, Vitarelli A, Puglisi G, De Vito C, Villari P, Allegra L.

Lung. 2010 Aug;188(4):321-9. doi: 10.1007/s00408-009-9222-y. Epub 2010 Jan 12.

PMID:
20066539
10.

Evaluating health-related quality of life, work ability, and disability in pulmonary arterial hypertension: an unmet need.

Rubenfire M, Lippo G, Bodini BD, Blasi F, Allegra L, Bossone E.

Chest. 2009 Aug;136(2):597-603. doi: 10.1378/chest.08-1260. Review.

PMID:
19666759
11.

Chlamydia pneumoniae and acute aortic syndrome: a call for a multi-institutional study.

Bossone E, Trimarchi S, Esposito G, Aliberti S, Citro R, Allegra L, Blasi F.

Monaldi Arch Chest Dis. 2008 Jun;70(2):68-70.

PMID:
18754273
12.

Comment on "Emissions from brake linings and tires: case studies of Stockholm, Sweden 1995/1998 and 2005".

Cetta F, Dhamo A, Schiraldi G, Allegra L.

Environ Sci Technol. 2008 Apr 1;42(7):2708-9; author reply 2710. No abstract available.

PMID:
18505020
13.

[Echocardiography and pulmonary arterial hypertension].

Bossone E, Citro R, Ruggiero A, Kuersten B, Gregorio G, Blasi F, Allegra L.

Monaldi Arch Chest Dis. 2007 Dec;68(4):219-26. Review. Italian.

PMID:
18361220
14.

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis.

Blasi F, Aliberti S, Tarsia P, Santus P, Centanni S, Allegra L.

Int J Chron Obstruct Pulmon Dis. 2007;2(1):27-31. Review.

15.

Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice.

Blasi F, Aliberti S, Allegra L, Piatti G, Tarsia P, Ossewaarde JM, Verweij V, Nijkamp FP, Folkerts G.

Respir Res. 2007 Nov 19;8:83.

16.

Echocardiography in pulmonary arterial hypertension: An essential tool.

Bossone E, Citro R, Blasi F, Allegra L.

Chest. 2007 Feb;131(2):339-41. No abstract available.

PMID:
17296630
17.

Lung function in beta-thalassemia patients: a longitudinal study.

Piatti G, Allegra L, Fasano V, Gambardella C, Bisaccia M, Cappellini MD.

Acta Haematol. 2006;116(1):25-9.

PMID:
16809886
18.

Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination.

Brown RA, Allegra L, Matera MG, Page CP, Cazzola M.

Pulm Pharmacol Ther. 2006;19(6):419-24. Epub 2006 May 10.

PMID:
16807023
19.

Anxiety and depression in COPD patients: The roles of gender and disease severity.

Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, Allegra L, Centanni S.

Respir Med. 2006 Oct;100(10):1767-74. Epub 2006 Mar 13.

20.
21.

Chlamydia pneumoniae and Mycoplasma pneumoniae.

Blasi F, Tarsia P, Aliberti S, Cosentini R, Allegra L.

Semin Respir Crit Care Med. 2005 Dec;26(6):617-24. Review.

PMID:
16388430
22.

Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.

Cazzola M, Salvatori E, Dionisio P, Allegra L.

Pulm Pharmacol Ther. 2006;19 Suppl 1:30-7. Epub 2005 Dec 15. Review.

PMID:
16359895
23.

Highlights on the appropriate use of fluoroquinolones in respiratory tract infections.

Blasi F, Tarsia P, Aliberti S, Santus P, Allegra L.

Pulm Pharmacol Ther. 2006;19 Suppl 1:11-9. Epub 2005 Nov 28. Review.

PMID:
16310389
24.

Azithromycin and lower respiratory tract infections.

Blasi F, Cazzola M, Tarsia P, Cosentini R, Aliberti S, Santus P, Allegra L.

Expert Opin Pharmacother. 2005 Oct;6(13):2335-51. Review.

PMID:
16218893
25.

Combination therapy in COPD: different response of COPD stages and predictivity of functional parameters.

Terzano C, Petroianni A, Ricci A, Allegra L.

Eur Rev Med Pharmacol Sci. 2005 Jul-Aug;9(4):209-15.

PMID:
16128040
26.

Pulmonary arterial hypertension: the key role of echocardiography.

Bossone E, Bodini BD, Mazza A, Allegra L.

Chest. 2005 May;127(5):1836-43. Review.

PMID:
15888866
27.

Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease.

Allegra L, Blasi F, Diano P, Cosentini R, Tarsia P, Confalonieri M, Dimakou K, Valenti V.

Respir Med. 2005 Jun;99(6):742-7. Epub 2004 Dec 10.

28.

Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness.

Terzano C, Petroianni A, Ricci A, D'Antoni L, Allegra L.

Eur Rev Med Pharmacol Sci. 2004 Nov-Dec;8(6):259-64.

PMID:
15745385
29.

Effects of salmeterol on cilia and mucus in COPD and pneumonia patients.

Piatti G, Ambrosetti U, Santus P, Allegra L.

Pharmacol Res. 2005 Feb;51(2):165-8.

PMID:
15629263
30.

Non-phospholipid vesicles for pulmonary glucocorticoid delivery.

Terzano C, Allegra L, Alhaique F, Marianecci C, Carafa M.

Eur J Pharm Biopharm. 2005 Jan;59(1):57-62.

PMID:
15567302
31.

Potential role of antibiotics in the treatment of asthma.

Blasi F, Cosentini R, Tarsia P, Allegra L.

Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):237-42. Review.

PMID:
15379591
32.

Adenosine 5'-monophosphate increases levels of leukotrienes in breath condensate in asthma.

Bucchioni E, Csoma Z, Allegra L, Chung KF, Barnes PJ, Kharitonov SA.

Respir Med. 2004 Jul;98(7):651-5.

33.

Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke.

Gianazza E, Allegra L, Bucchioni E, Eberini I, Puglisi L, Blasi F, Terzano C, Wait R, Sirtori CR.

Am J Med. 2004 Jul 1;117(1):51-4. No abstract available.

PMID:
15210388
34.

Chlamydia pneumoniae: crossing the barriers?

Blasi F, Centanni S, Allegra L.

Eur Respir J. 2004 Apr;23(4):499-500. No abstract available.

35.

Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.

Wilson R, Allegra L, Huchon G, Izquierdo JL, Jones P, Schaberg T, Sagnier PP; MOSAIC Study Group.

Chest. 2004 Mar;125(3):953-64.

PMID:
15006954
36.

High levels of interleukin-6 in the exhaled breath condensate of patients with COPD.

Bucchioni E, Kharitonov SA, Allegra L, Barnes PJ.

Respir Med. 2003 Dec;97(12):1299-302.

37.

An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients.

Grimaldi LM, Pincherle A, Martinelli-Boneschi F, Filippi M, Patti F, Reggio A, Franciotta D, Allegra L, Comi G, Blasi F.

Mult Scler. 2003 Oct;9(5):467-71.

PMID:
14582771
38.

Effect of zafirlukast on methacholine and ultrasonically nebulized distilled water challenge in patients with mild asthma.

Carratù P, Morelli N, Freire AX, Pugazhenthi M, Guerra S, Umberger R, Allegra L.

Respiration. 2003 May-Jun;70(3):249-53.

PMID:
12915743
39.

Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infections.

Blasi F, Tarsia P, Cosentini R, Cazzola M, Allegra L.

Expert Opin Investig Drugs. 2003 Jul;12(7):1165-77. Review.

PMID:
12831351
40.

In vitro antibiotic activity against Chlamydia pneumoniae clinical isolates.

Blasi F, Drago L, Gismondo MR, Cosentini R, Tarsia P, Valenti V, Capone P, Allegra L.

J Chemother. 2003 Feb;15(1):93-4. No abstract available.

PMID:
12678424
41.

On the association between date of birth and pollen sensitization: is age an effect modifier?

Guerra S, Sherrill DL, Cottini M, Michetti G, Allegra L.

Allergy Asthma Proc. 2002 Sep-Oct;23(5):303-10.

PMID:
12476539
42.

Importance of drug delivery system in steroid aerosol therapy via nebulizer.

Terzano C, Allegra L.

Pulm Pharmacol Ther. 2002;15(5):449-54.

PMID:
12406667
43.

Human neutrophil oxidative bursts and their in vitro modulation by different N-acetylcysteine concentrations.

Allegra L, Dal Sasso M, Bovio C, Massoni C, Fonti E, Braga PC.

Arzneimittelforschung. 2002;52(9):669-76.

PMID:
12404881
44.

Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment.

Blasi F, Damato S, Cosentini R, Tarsia P, Raccanelli R, Centanni S, Allegra L; Chlamydia InterAction with COPD (CIAC) Study Group.

Thorax. 2002 Aug;57(8):672-6.

45.

Community-acquired pneumonia: role of atypical organisms.

Cosentini R, Tarsia P, Blasi F, Roma E, Allegra L.

Monaldi Arch Chest Dis. 2001 Dec;56(6):527-34. Review.

PMID:
11980285
46.

Epidemiology of Chlamydia pneumoniae.

Blasi F, Tarsia P, Arosio C, Fagetti L, Allegra L.

Clin Microbiol Infect. 1998 Jan;4 Suppl 4:S1-S6.

47.

Effectiveness of beclomethasone dipropionate aerosolized through different nebulizers to asthmatic patients.

Terzano C, Guerra S, Allegra L.

Eur Rev Med Pharmacol Sci. 2001 Mar-Apr;5(2):43-51.

PMID:
11863318
48.

Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma.

Terzano C, Allegra L, Barkai L, Cremonesi G.

Eur Rev Med Pharmacol Sci. 2001 Jan-Feb;5(1):17-24.

PMID:
11860218
49.

Increased frequency dependence of specific airway resistance in patients with laryngeal hemiplegia.

Fasano V, Raiteri L, Bucchioni E, Guerra S, Cantarella G, Massari MG, Cesana BM, Allegra L.

Eur Respir J. 2001 Dec;18(6):1003-8.

50.

Atopy prevalence and spirometric performance in asymptomatic schoolchildren exposed to air pollution.

Centanni S, Di Marco F, Castagna F, Santus P, Guarnieri R, Allegra L.

Monaldi Arch Chest Dis. 2001 Aug;56(4):304-8.

PMID:
11770209

Supplemental Content

Loading ...
Support Center